TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.49
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
0.82
Today|||52-Week Range
3.88
+49.18%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Menzel Garry E
President & Chief Executive Officer
Sale12/06/202214,886$1.35$20.1K+13.21%
Menzel Garry E
President & Chief Executive Officer
Sale12/02/20228,408$1.39$11.7K+6.38%
Menzel Garry E
President & Chief Executive Officer
Sale12/05/20228,530$1.37$11.7K+9.49%
Menzel Garry E
President & Chief Executive Officer
Sale12/12/202210,613$1.10$11.7K+35.14%
Menzel Garry E
President & Chief Executive Officer
Sale12/09/202210,325$1.13$11.7K+31.58%
Menzel Garry E
President & Chief Executive Officer
Sale12/07/20229,111$1.28$11.7K+18.11%
Menzel Garry E
President & Chief Executive Officer
Sale12/13/202211,000$1.06$11.7K+50.00%
Menzel Garry E
President & Chief Executive Officer
Sale12/08/20229,314$1.25$11.6K+27.12%
Quintas Cardama Alfonso
Chief Medical Officer
Sale12/08/20224,014$1.26$5.1K+27.12%
Quintas Cardama Alfonso
Chief Medical Officer
Sale12/02/20223,636$1.39$5.1K+6.38%
Page of 5